Highlands Oncology Group, PA is a clinical research site located in Springdale, Arkansas, United States 72762.
Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.
Highlands Oncology Group, PA has participated in 14 clinical trials with 11 currently active.
Therapeutic areas: Multiple Myeloma (MM), Melanoma, Non-small Cell Lung Cancer.
Sponsors: Shanghai Henlius Biotech, Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Arkansas · View every site in Springdale
Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Highlands Oncology Group, PA has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Highlands Oncology Group, PA has 14 clinical trials on record, with 11 currently active. Their work covers Multiple Myeloma (MM), Melanoma, Non-small Cell Lung Cancer.
Highlands Oncology Group, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.